Luis E. Raez, MD, discusses when minimal residual disease testing can be performed as an option for patients with lung cancer.

Researchers have developed a way of detecting circulating tumor cells in the bloodstream of pancreatic cancer and lung cancer patients.

Lung cancer, notorious for its high mortality rates, is a leading cause of cancer-related deaths globally, with metastasis ...

Significant advancements in lung cancer treatment were seen throughout 2024, from new drug approvals to promising clinical ...